{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:29:02Z","timestamp":1775024942873,"version":"3.50.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T00:00:00Z","timestamp":1389657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0083413","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T16:09:22Z","timestamp":1389715762000},"page":"e83413","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya"],"prefix":"10.1371","volume":"9","author":[{"given":"Doris W.","family":"Njomo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dunstan A.","family":"Mukoko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nipher K.","family":"Nyamongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Karanja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,1,14]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (1995b) World Health Report, Geneva. pp118."},{"key":"ref2","unstructured":"World Health Organization (2000c) Operational guidelines for rapid mapping of Bancroftian filariasis in Africa World Health Organization."},{"key":"ref3","first-page":"417","article-title":"Lymphatic filariasis: progress of disability prevention activities","volume":"79","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"key":"ref4","first-page":"b 1686","article-title":"The end of lymphatic filariasis?","volume":"338","author":"M Bockarie","year":"2009","journal-title":"Tropical Diseases. British Medical Journal"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1017\/S0031182000066646","article-title":"Re-assessing the global prevalence and distribution of lymphatic filariasis","volume":"112","author":"E Micheal","year":"1996","journal-title":"Parasitology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.trstmh.2008.04.039","article-title":"Impact of two rounds of mass treatment with diethylcarbamazine plus albendazole on <italic>Wuchereriabancrofti<\/italic> infection and the sensitivity of immunochromatographic test in Malindi, Kenya","volume":"102","author":"SM Njenga","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref7","first-page":"1","article-title":"Recommendations of the International Task Force for Disease Eradication","volume":"42","year":"1993","journal-title":"MMWR Recomm Rep"},{"key":"ref8","first-page":"9","article-title":"Combination ivermectin plus diethylcarbamazine, a new effective tool for control of lymphatic filariasis","volume":"46","author":"JP Moulia-Pelat","year":"1995","journal-title":"Trop Med Parasitol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0169-4758(95)80128-6","article-title":"Lymphatic filariasis infection and disease: Control Strategies","volume":"11","author":"EA Ottesen","year":"1995","journal-title":"Parasitology Today"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0035-9203(98)90972-5","article-title":"Efficacy of single dose combination of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis","volume":"92","author":"MM Ismail","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-3156.2000.00620.x","article-title":"The global programme to eliminate lymphatic filariasis","volume":"5","author":"EA Ottesen","year":"2000","journal-title":"Trop Med Int Health"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2471\/BLT.06.034108","article-title":"Unfulfilled potential, using diethylcarbamazine- fortified salt to eliminate lymphatic filariasis","volume":"85","author":"P Lammie","year":"2007","journal-title":"Bull World Health Organ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1086\/378354","article-title":"Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study","volume":"188","author":"WA Stolk","year":"2003","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0038-1634505","article-title":"The LYMFASIM simulation program for modeling lymphatic filariasis and its control","volume":"37","author":"AP Plaisier","year":"1998","journal-title":"Methods Inf Med"},{"issue":"2","key":"ref15","first-page":"1","article-title":"Eliminating Lymphatic Filariasis","volume":"68","author":"K Ichimori","year":"2011","journal-title":"Bol Med Hosp Infant Mex"},{"key":"ref16","first-page":"333","article-title":"Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration","volume":"83","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2883-6-11","article-title":"Social mobilization, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka","volume":"6","author":"MV Weerasooriya","year":"2007","journal-title":"Filaria J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-3156.2004.01247.x","article-title":"Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa India","volume":"9","author":"BV Babu","year":"2004","journal-title":"Trop Med Int Health"},{"key":"ref19","unstructured":"World Health Organization (2004) Lymphatic Filariasis Elimination Programme. Training module for drug distributors in countries where lymphatic filariasis is not co-endemic with onchocerciasis."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/1755-6783.95962","article-title":"Socio-economic factors associated with Compliance with Mass Drug Administration for Lymphatic Filariasis Elimination in Kenya: Descriptive study results","volume":"5","author":"DW Njomo","year":"2012","journal-title":"Ann Trop Med Public Health"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/10158782.2012.11441487","article-title":"Factors associated with the motivation of community drug distributors in the Lymphatic Filariasis Elimination Programme in Kenya","volume":"2","author":"DW Njomo","year":"2012","journal-title":"South Afr J Epidemiol Infect"},{"key":"ref22","unstructured":"Kenya Population and housing census highlights (2009) Kenya National Bureau of Statistics. pp. 1\u20138."},{"key":"ref23","article-title":"Factors that contribute to the low uptake of skilled care during delivery in Malindi, Kenya","author":"A Carter","year":"2010","journal-title":"SIT Study Abroad"},{"key":"ref24","first-page":"145","article-title":"The use of focus groups in social and behavioral research: some methodological issues","volume":"44","author":"ME Khan","year":"1991","journal-title":"World HealthStatistics Quarterly"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2883-6-7","article-title":"Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience","volume":"6","author":"B Nandha","year":"2007","journal-title":"Filaria Journal"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1179\/000349809X12459740922255","article-title":"Mass drug administration against filariasis in India: perceptions and practices in a rural community in Kerala","volume":"7","author":"S Aswathy","year":"2009","journal-title":"Annals ofTropical Medicine & Parasitology Vol. 103"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-3305-3-48","article-title":"Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia","volume":"3","author":"D Yirga","year":"2010","journal-title":"Parasites and Vectors"},{"key":"ref28","first-page":"42","article-title":"Social Mobilization and Compliance with Mass Treatment for Lymphatic Filariasis Elimination in Kenya","volume":"20","author":"DW Njomo","year":"2012","journal-title":"Afr J Health Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-1-14","article-title":"Factors associated with acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines","volume":"1","author":"ML Amarillo","year":"2008","journal-title":"Parasites and Vectors"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4269\/ajtmh.2008.79.480","article-title":"Determinants of Success in National Programs to Eliminate Lymphatic Filariasis: A Perspective Identifying Essential Elements and Research Needs","volume":"79","author":"D Kyelem","year":"2008","journal-title":"Amer Journal Trop MedHyg"},{"issue":"1","key":"ref31","first-page":"1","article-title":"Coverage and compliance of mass drug administration programme against filariasis in Bijapur District, Karnataka","volume":"1","author":"MK Muralidhar","year":"2013","journal-title":"J Pub Health Med Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/0970-0218.103468","article-title":"Elimination of Lymphatic Filariasis, Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka","volume":"37","author":"TS Ranganath","year":"2012","journal-title":"Indian J Community Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0083413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T10:12:28Z","timestamp":1565086348000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0083413"}},"subtitle":[],"editor":[{"given":"Clive","family":"Shiff","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,14]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0083413","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,14]]}}}